RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?

J Clin Oncol. 2015 Apr 1;33(10):1223-4. doi: 10.1200/JCO.2014.59.6908. Epub 2015 Feb 23.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Squamous Cell / therapy*
  • Chemoradiotherapy*
  • Female
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Male